Tentative Xeljanz XR Approval Among Several For Zydus Cadila
Final Gilenya Approval Also In The Bag
Zydus Cadila has clocked up two tentative and four final abbreviated new drug application approvals in a short amount of time, including for Boehringer Ingelheim’s Jentadueto and the discontinued verapamil hydrochloride for injection.